Everything below concerns angiogenesis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic pentadecapeptide | Composed of fifteen amino acid residues |
| Amino acid sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | Single-letter form GEPPPGKPADDAGLV |
| Original source | Fragment of a protein in human gastric juice | First characterized in the 1990s |
| Number in name | 157 | Refers to the fragment's position in the source protein |
| Human trial evidence | Limited | Preclinical rodent data predominate |
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Preservation and reconstruction of transaction records: The MLA states that all transaction records must be stored for a minimum of five years, and should be preserved in a way that they can be readily accessible when in need. Pre-launch assessment of new technologies or products: From henceforth all new technologies must be assessed for money laundering and terrorism risks, and appropriate measures must be taken to manage and mitigate the risks. Establishment of the Special Control Unit against Money Laundering: The act established and statutorily backed this body to monitor and oversee the operations of non-financial institutions. And this body works under the EFCC. Financial transaction and reporting: All transactions exceeding N5 million for individuals and N10 million for corporate bodies, must be reported by all financial institutions to the Nigerian Financial Intelligence Unit. Other measures have been taken by the government to prevent money laundering. In May 2022, President Muhammadu Buhari signed into law three bills. These bills are; Money laundering (Prevention and Prohibition bill), 2022, the Terrorism (Prevention and Prohibition bill) 2022, and the Proceeds of Crime (Recovery and Management) Bill, 2022. The Central Bank of Nigeria also listed Regulations to prevent Money laundering in Nigeria.
Quercetin is the aglycone form of a number of other flavonoid glycosides, such as rutin (also known as quercetin-3-O-rutinoside) and quercitrin, found in citrus fruit, buckwheat, and onions. Quercetin forms the glycosides quercitrin and rutin together with rhamnose and rutinose, respectively. Likewise guaijaverin is the 3-O-arabinoside, hyperoside is the 3-O-galactoside, isoquercitin is the 3-O-glucoside and spiraeoside is the 4′-O-glucoside. CTN-986 is a quercetin derivative found in cottonseeds and cottonseed oil. Miquelianin is the quercetin 3-O-β-D-glucuronopyranoside. Several taxifolin (also known as dihydroquercetin) glycosides also exist. Isoquercetin is the 3-O-glucoside of quercetin.
== Clinical significance == MT-TD mutations have been associated with complex IV deficiency of the mitochondrial respiratory chain, also known as cytochrome c oxidase deficiency. Cytochrome c oxidase deficiency is a rare genetic condition that can affect multiple body parts, including skeletal muscles, the heart, the brain, or the liver. Common clinical manifestations include myopathy, hypotonia, and encephalomyopathy, lactic acidosis, and hypertrophic cardiomyopathy. A patient with a 7526A>G mutation in the MT-TD gene exhibited gradually worsening symptoms of exercise intolerance, increased creatine kinase levels, sustained exercise leading to muscle pains and general malaise. A patient with a 7543A>G mutation also exhibited symptoms of the disease.
==== 500–599 ==== Water Supply and Sewerage Services (Customer Service Standards) (Amendment) Regulations 1993 (S.I. 1993/500) Local Government Finance Act 1992 (Community Charge Benefits) Saving Order 1993 (S.I. 1993/502) Bovine Animals (Identification, Marking and Breeding Records) (Amendment) Order 1993 (S.I. 1993/503) Prisoner Escorts Rules 1993 (S.I. 1993/515) Prison (Amendment) Rules 1993 (S.I. 1993/516) Common Agricultural Policy (Wine) Regulations 1993 (S.I. 1993/517) Social Security Benefits (Miscellaneous Amendments) Regulations 1993 (S.I. 1993/518) Occupational and Personal Pension Schemes (Miscellaneous Amendments) Regulations 1993 (S.I. 1993/519) Local Authorities (Capital Finance) (Amendment) Regulations 1993 (S.I. 1993/520) National Health Service (General Medical and Pharmaceutical Services) (Scotland) Amendment Regulations 1993 (S.I. 1993/521) National Health Service (Charges for Drugs and Appliances) (Scotland) Amendment Regulations 1993 (S.I. 1993/522) National Health Service (Dental Services) (Miscellaneous Amendments) (Scotland) Regulations 1993 (S.I. 1993/523) National Health Service (Optical Charges and Payments) (Scotland) Amendment Regulations 1993 (S.I. 1993/524) Education (Fees and Awards) (Scotland) Amendment Regulations 1993 (S.I. 1993/525) Council Tax (Dwellings) (Scotland) Regulations 1993 (S.I. 1993/526) Council Tax (Transitional Reduction Scheme) (Scotland) Amendment (No.2) Regulations 1993 (S.I. 1993/527) Legal Aid in Contempt of Court Proceedings (Scotland) Amendment Regulations 1993 (S.I.
== Natural occurrence == Potassium alum dodecahydrate occurs in nature as a sulfate mineral called alum-(K), typically as encrustations on rocks in areas of weathering and oxidation of sulfide minerals and potassium-bearing minerals. In the past, potassium alum has been obtained from alunite (KAl(SO4)2·2Al(OH)3), mined from sulfur-containing volcanic sediments. Alunite is an associate and likely potassium and aluminium source. It has been reported at Vesuvius, Italy; east of Springsure, Queensland; in Alum Cave, Tennessee; Alum Gulch, Santa Cruz County, Arizona and the Philippine island of Cebu. In order to obtain alum from alunite, it is calcined and then exposed to the action of air for a considerable time. During this exposure it is kept continually moistened with water, so that it ultimately falls to a very fine powder. This powder is then lixiviated with hot water, the liquor decanted, and the alum allowed to crystallize. The undecahydrate also occurs as the fibrous mineral kalinite (KAl(SO4)2·12H2O).
Sources: en.wikipedia.org
A large number of alternative synthetic routes to amphetamine have been developed based on classic organic reactions. One example is the Friedel–Crafts alkylation of benzene by allyl chloride to yield beta chloropropylbenzene which is then reacted with ammonia to produce racemic amphetamine (method 2). Another example employs the Ritter reaction (method 3). In this route, allylbenzene is reacted acetonitrile in sulfuric acid to yield an organosulfate which in turn is treated with sodium hydroxide to give amphetamine via an acetamide intermediate. A third route starts with ethyl 3-oxobutanoate which through a double alkylation with methyl iodide followed by benzyl chloride can be converted into 2-methyl-3-phenyl-propanoic acid. This synthetic intermediate can be transformed into amphetamine using either a Hofmann or Curtius rearrangement (method 4). A significant number of amphetamine syntheses feature a reduction of a nitro, imine, oxime, or other nitrogen-containing functional groups. In one such example, a Knoevenagel condensation of benzaldehyde with nitroethane yields phenyl-2-nitropropene. The double bond and nitro group of this intermediate is reduced using either catalytic hydrogenation or by treatment with lithium aluminium hydride (method 5). Another method is the reaction of phenylacetone with ammonia, producing an imine intermediate that is reduced to the primary amine using hydrogen over a palladium catalyst or lithium aluminum hydride (method 6).
== History and uses == Ceramic petrography is used in academic archaeological research and commercial archaeology to address a range of issues. A common goal is tracing the movement of pottery and associated trade through provenance determination. The principle of provenance ascription with ceramic petrography relies on the fact that "the mineral and rock inclusions within a paste are a reflection of the geology of the source area of the ceramics" and that potters did not transport ceramic raw materials over significant distances. An equally important concern is the nature of ancient ceramic production and its meaning in terms of the knowledge, skills, identity and traditions of potters. As synthetic materials, ceramics are "sensitive indicators of human decision making and materials interaction". By examining microstructural evidence for processes such as clay paste preparation, forming and firing, ceramic petrographers can reconstruct the steps involved in the production of ceramic artefacts. Ceramic petrography originated in the American Southwest with the work of Anna O. Shepard but has mainly been developed in the Old World in the later half of the 20th century. Other early studies include the work of David Peacock and his students in the UK Ceramic petrography continues to be applied to the interpretation of British ceramics and is used heavily in the prehistoric Aegean. In the USA the approach is less popular, though important contributions have been made in the area of quantitative petrography.
In the initial step, 2-Amino-5-bromobenzophenone undergoes acylation, leveraging its amino group with a lone pair on the nitrogen atom. This lone pair facilitates a nucleophilic attack, where the nitrogen attacks the carbon of chloroacetyl chloride, inducing a negatively charged oxygen. Subsequently, the oxygen re-establishes the carbon-oxygen double bond, expelling a chloride ion, leading to the formation of bromoacetamide-2-chloro-5-benzophenone. Following this, bromoacetamide-2-chloro-5-benzophenone engages in a nucleophilic substitution reaction with ammonium hydroxide as a nucleophile, replacing the second chloride ion with ammonia. This reaction yields 2-amino-N-(2-benzoyl-4-bromophenyl)acetamide. Upon the formation of 2-amino-N-(2-benzoyl-4-bromophenyl)acetamide, an intramolecular reaction ensues, resulting in 7-bromo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one, characterized by a seven-membered ring known as diazepine. Subsequently, through the aid of acetohydrazide, another acylation event takes place, giving rise to a 1,2,4-triazole ring and ultimately yielding bromazolam. This synthesis can also be used to obtain alprazolam by using 2-amino-5-chlorobenzophenone as the starting material.
=== Post-classical === In medieval warfare, military feeding remained essentially the same as it had been in prior centuries. Armies typically had to acquire food supplies from the territory they were passing through. This meant that large-scale looting by soldiers was unavoidable, and was actively encouraged in the 14th century with its emphasis on chevauchée tactics, where mounted troops would burn and pillage enemy territory in order to distract and demoralize the enemy while denying them supplies. Through the medieval period, soldiers were responsible for supplying themselves, either through foraging, looting, or purchases. However, military commanders often provided their troops with food and supplies, but this would be provided instead of the soldiers' wages, or soldiers would be expected to pay for it from their wages, either at cost or even with a profit. During the Crusades, Crusaders carried foods such as dried meat and grain which could be used to make porridge and bought additional foods such as fruits, vegetables, and cheese locally. They also foraged and plundered for food. During the First Crusade, soldiers would have provided their own food, which could have meant mortgaging property or selling possessions to buy it. At the Siege of Antioch, the Crusaders' food supplies ran so low that a large force was sent away to forage and plunder food, opening the rest of the force up to a counterattack. At the subsequent Siege of Ma'arra, hunger among the Crusaders was so widespread that some resorted to cannibalism, feeding on the bodies of Muslims.
The fusion of droplets with different contents can also be exploited for reagent addition. Electro-coalescence merges pairs of droplets by applying an electric field to temporarily destabilize the droplet-droplet interface to achieve reproducible droplet fusion in surfactant-stabilized emulsions. Electro-coalescence requires droplets (which are normally separated by the continuous phase) to come into contact. By manipulating droplet size in separate streams, differential flow of droplet sizes can bring droplets into contact before merging. Another method for facilitating droplet fusion is acoustic tweezing. While droplets are flowing in microfluidic channels, they can be immobilised using an acoustic tweezer based on surface acoustic waves. Once a droplet is held with the acoustic tweezer, consecutive droplets collide into it and fusion takes place.
Sources: en.wikipedia.org
=== Phosphoenolpyruvate carboxykinase (PEPC-K) === Glyceroneogenesis can be regulated at two reaction pathways. First, it can be held at the decarboxylation of oxaloacetate to phosphoenolpyruvate. Secondly, the TCA cycle can affect glyceroneogenesis when the glutamate or substrates in the TCA cycle are being used as a precursor. Decarboxylation of oxaloacetate to phosphoenolpyruvate is catalyzed by PEPC-K, the essential enzyme which regulates glyceroneogenesis. Increases in PEPC-K levels or overexpression of the gene that codes for PEPC-K will increase glyceroneogenesis. Also, oxaloacetate can be decarboxylated to phosphoenolpyruvate when more PEPC-K can catalyze the reaction. Gene expression of PEPC-K can be suppressed by norepinephrine, glucocorticoids, and insulin. Norepinephrine is a neurotransmitter which decreases the activity of PEPC-K when the cell is in a cold environment. Glucocorticoids are steroid hormones involved in the reciprocal regulation of glyceroneogenesis in the liver and adipose tissues. Through a poorly-understood mechanism, they induce transcription of PEPC-K in the liver while decreasing transcription in adipose tissues. Insulin is a peptide hormone that causes cells to take in glucose. Through glyceroneogenesis, insulin down-regulates the expression of PEPC-K in both liver and adipose tissues.
In November 2024, an investigation by The Washington Post further corroborated these investigations, with witnesses, victims, and an Israeli soldier stating civilians were being used as human shields to prevent harm to Israeli soldiers. An investigation by the DCIP detailed that the Israeli army is "systematically" detaining and torturing children. Israel used several children as human shields in the Al-Tuffah area of Gaza City on 27 December 2023. On that occasion, 50 Palestinians were detained, including children. Two brothers, aged 12 and 13, told investigators that soldiers forced them to strip off, tied their hands and forced them to walk in front of Israeli tanks along with other Palestinians. The younger brother also reported being slapped, kicked and beaten. In November 2024, Defence for Children International reported on three separate incidents, during 15–20 October 2024, of families with young children being used as human shields to protect the Israel Defense Forces in attacks at the Jabalia refugee camp and Indonesia Hospital.
About 55% of blood is blood plasma, a fluid that is the blood's liquid medium, which by itself is straw-yellow in color. The total blood plasma volume in an average human is 2.7–3.0 liters (2.8–3.2 quarts). It is essentially an aqueous solution containing 92% water, 8% blood plasma proteins, and trace amounts of other materials. Plasma circulates dissolved nutrients, such as glucose, amino acids, and fatty acids (dissolved in the blood or bound to plasma proteins), and removes waste products, such as carbon dioxide, urea, and lactic acid. Other important components include:
=== Tandem in space MS/MS modes === When tandem MS is performed with an in space design, the instrument must operate in one of a variety of modes. There are a number of different tandem MS/MS experimental setups and each mode has its own applications and provides different information. Tandem MS in space uses the coupling of two instrument components which measure the same mass spectrum range but with a controlled fractionation between them in space, while tandem MS in time involves the use of an ion trap. There are four main scan experiments possible using MS/MS: precursor ion scan, product ion scan, neutral loss scan, and selected reaction monitoring. For a precursor ion scan, the product ion is selected in the second mass analyzer, and the precursor masses are scanned in the first mass analyzer. Note that precursor ion is synonymous with parent ion and product ion with daughter ion; however the use of these anthropomorphic terms is discouraged. In a product ion scan, a precursor ion is selected in the first stage, allowed to fragment and then all resultant masses are scanned in the second mass analyzer and detected in the detector that is positioned after the second mass analyzer. This experiment is commonly performed to identify transitions used for quantification by tandem MS. In a neutral loss scan, the first mass analyzer scans all the masses. The second mass analyzer also scans, but at a set offset from the first mass analyzer. This offset corresponds to a neutral loss that is commonly observed for the class of compounds.
Sources: en.wikipedia.org
It is a chain of fifteen amino acids, referred to as a pentadecapeptide. The sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It corresponds to a fragment of a protein found in human gastric juice.
It is neither a naturally circulating hormone nor an approved medicine in most countries. It is a synthetic peptide fragment used chiefly as a laboratory research material. Its regulatory status varies by jurisdiction, and it is not authorized as a therapeutic product in the United States or the European Union.
Published human evidence is very limited. Most findings come from rodent studies conducted by a small number of groups. As a result, statements about its effects in humans are generally described as uncertain rather than established.
The lyophilized powder is normally kept at minus twenty degrees Celsius or colder. Solutions are held at refrigerator temperature or below and protected from light. Repeated freezing and thawing is avoided because it can promote aggregation or loss of activity.